APA (7th ed.) Citation

Xue, C., Yang, B., Xu, J., Zhou, C., Zhang, L., Gao, X., . . . Xu, C. (2021). Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: A systematic review and meta-analysis. Clinical Kidney Journal, 14(4), 1042-1054. https://doi.org/10.1093/ckj/sfaa191

Chicago Style (17th ed.) Citation

Xue, Cheng, et al. "Efficacy and Safety of Rituximab in Adult Frequent-relapsing or Steroid-dependent Minimal Change Disease or Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis." Clinical Kidney Journal 14, no. 4 (2021): 1042-1054. https://doi.org/10.1093/ckj/sfaa191.

MLA (9th ed.) Citation

Xue, Cheng, et al. "Efficacy and Safety of Rituximab in Adult Frequent-relapsing or Steroid-dependent Minimal Change Disease or Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis." Clinical Kidney Journal, vol. 14, no. 4, 2021, pp. 1042-1054, https://doi.org/10.1093/ckj/sfaa191.